BioSpace News Archive

 I. Yvan Miklin has been named new FIBO USA Ambassador – the latest sign of the Aquila’s increasingly supportive collaboration in American and Global Health and Fitness Events

The following statement is posted regarding the ongoing review of the comparative clinical effectiveness and value of treatments for peanut allergy currently being conducted by the Institute for Clinical and Economic Review (ICER) and is co-signed by the following organizations: Food Allergy Research & Education (FARE), the American College of Allergy, Asthma and Immunology and the Allergy & Asthma Network.

The Medical Device Innovation Consortium (MDIC), announced that CVRx’s President and CEO Nadim Yared has been named chairman of the MDIC Board of Directors and Executive Committee for a two-year term

Paradigm, the industry leader in solving catastrophic and complex health care challenges and improving lives, announced today the promotion of Kevin Turner to Chief Executive Officer (CEO) of the Catastrophic Care Management division and the appointment of Karen Jones to the newly created role of Chief Human Resources Officer (CHRO).

The Advisory Council on the Implementation of National Pharmacare’s Final Report highlights the importance of biosimilar medicines in the sustainable implementation of a national pharmacare program

Demers Ambulances, an industry leader in the global fire apparatus manufacturing market, announced that Penn Care is their new dealer for Ohio and West Virginia.

Grady Health System is proud to announce its new Marcus Stroke Scholars Program.

Surterra Wellness (Surterra), one of the fastest growing health and wellness companies in the United States (U.S.), today announced that former Patrón Spirits CEO Ed Brown has joined the company as Executive Director

Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will present at the upcoming Raymond James Life Sciences and MedTech Conference taking place June 18-19, 2019 in New York, NY.

RxFunction, Inc. has announced the market launch of Walkasins®, a wearable lower limb sensory neuroprosthesis that helps improve balance and gait in patients who experience balance problems due to sensory peripheral neuropathy.